| Followers | 177 |
| Posts | 11263 |
| Boards Moderated | 0 |
| Alias Born | 04/04/2011 |
Monday, December 19, 2011 7:21:26 AM
Really? If what you say is correct, which I can't verify, why are we suppose to take your word that what you say is stated as fact? If what we all want is documented proof, then it would apply to all, be it those who are for or against.
I do however support the need for documented proof on anything related with CGAQ. Just seems that it show flow both ways and just because someone was a former IR for CGAQ, does not make what he post as fact, which has been proven here in several cases. It also shows that tons of statements are made continuously here regarding CGAQ, be it for or against that can not be substantiated with real proof. Thus making most what is posted here as hearsay or opinion only. Especially when one uses such sources as a stable worker at the track. I mean come on, Really?
Not saying what you posted is incorrect, but what I am saying is that almost everything posted on this board is opinion only. This is a pink sheet stock where anything goes, including the risk associated with it. We will not know for sure of anything until it is supported with verifiable factual information. Until then it is a crap shoot and in the end we will see how it plays out.
Cheers! (Below is your quote)
I do however support the need for documented proof on anything related with CGAQ. Just seems that it show flow both ways and just because someone was a former IR for CGAQ, does not make what he post as fact, which has been proven here in several cases. It also shows that tons of statements are made continuously here regarding CGAQ, be it for or against that can not be substantiated with real proof. Thus making most what is posted here as hearsay or opinion only. Especially when one uses such sources as a stable worker at the track. I mean come on, Really?
Not saying what you posted is incorrect, but what I am saying is that almost everything posted on this board is opinion only. This is a pink sheet stock where anything goes, including the risk associated with it. We will not know for sure of anything until it is supported with verifiable factual information. Until then it is a crap shoot and in the end we will see how it plays out.
Cheers! (Below is your quote)
First of all we are talking about a PUBLIC BIDDING. Second
they have no idea they are not speaking to a citizen. Third
I am fortunate in that I know people in the D.R. that can and
have put me in a three way conversation with the proper parties.
Recent BSEM News
- BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026 • GlobeNewswire Inc. • 04/08/2026 11:00:00 AM
- BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/31/2026 08:05:00 PM
- BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025 • GlobeNewswire Inc. • 03/30/2026 11:00:00 AM
- BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/24/2026 08:05:00 PM
- BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair • GlobeNewswire Inc. • 03/23/2026 03:40:56 PM
- BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair • GlobeNewswire Inc. • 03/23/2026 11:00:00 AM
- BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026 • GlobeNewswire Inc. • 03/11/2026 08:05:00 PM
- BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference • GlobeNewswire Inc. • 02/20/2026 12:00:00 PM
- BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research • GlobeNewswire Inc. • 02/03/2026 09:05:00 PM
- BioStem Technologies Advances Entry into the Acute Wound Care Market with Acquisition of BioTissue Holdings’ Surgical and Wound Care Business • GlobeNewswire Inc. • 01/21/2026 10:30:00 PM
- BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes • GlobeNewswire Inc. • 01/07/2026 09:05:00 PM
- BioStem Technologies Products Placed on “12-Month Status Quo Period” List in Update to CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes • GlobeNewswire Inc. • 12/18/2025 12:00:00 PM
- BioStem Technologies® to Debut American Amnion™ at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference • GlobeNewswire Inc. • 12/10/2025 12:00:00 PM
- BioStem Technologies Expands Product Access in Medicaid • GlobeNewswire Inc. • 11/25/2025 01:59:13 PM
- BioStem Technologies Reports Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/13/2025 09:02:00 PM
- BioStem Technologies Announces Filing of Restated Financial Statements • GlobeNewswire Inc. • 11/13/2025 09:01:00 PM
- BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes • GlobeNewswire Inc. • 11/05/2025 09:05:00 PM
- BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters • GlobeNewswire Inc. • 11/05/2025 12:00:00 PM
- BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers • GlobeNewswire Inc. • 10/31/2025 11:00:00 AM
- BioStem Technologies to Host Third Quarter 2025 Financial Results Conference Call on November 13, 2025 • GlobeNewswire Inc. • 10/30/2025 08:05:00 PM
- BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant • GlobeNewswire Inc. • 10/27/2025 08:15:00 PM
- BioStem Technologies Expands Partnership with the Florida Panthers as a Sponsor for the 13th Season of the “Heroes Among Us” Program • GlobeNewswire Inc. • 10/02/2025 04:00:00 PM
